Skip to main content
. 2020 Apr 8;15(2):143–154. doi: 10.31616/asj.2019.0285

Fig. 2.

Fig. 2.

(A–C) Flow cytometry and immunocytochemistry studies for the characterization of primary human nucleus pulposus cells using the CD24 antibody.